SCHEMBL8042446

SCHEMBL8042446

COc1ccccc1C1CCN(CCCCN2C(=O)CCc3ccccc32)C1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 3/20 0.61
GRIN2B Q13224 3/20 0.61
DRD2 P14416 12/20 0.61
DRD3 P35462 12/20 0.61
DRD4 P21917 11/20 0.61
CHRM2 P08172 11/20 0.61
CHRM4 P08173 11/20 0.61
CHRM5 P08912 11/20 0.61
CHRM1 P11229 11/20 0.61
CHRM3 P20309 11/20 0.61
ADRB2 P07550 2/20 0.55
ADRB1 P08588 2/20 0.55
ADRA1D P25100 2/20 0.55
ADRA1A P35348 2/20 0.55
ADRA1B P35368 2/20 0.55
HTR7 P34969 4/20 0.54
MEN1 O00255 1/20 0.54
CYP1A2 P05177 1/20 0.54
HTR1A P08908 1/20 0.54
CYP2C9 P11712 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8042443 1.00 GRIN1 (0.61) GRIN1GRIN2BDRD2DRD3DRD4
Hydrochloric Acid SCHEMBL8045702 0.99 GRIN1 (0.60) GRIN1GRIN2BDRD2DRD3DRD4
Hydrochloric Acid SCHEMBL8045698 0.99 GRIN1 (0.60) GRIN1GRIN2BDRD2DRD3DRD4
SCHEMBL8042469 0.84 DRD2 (0.64) DRD2CHRM2CHRM4CHRM5CHRM1
SCHEMBL8042466 0.84 DRD2 (0.64) DRD2CHRM2CHRM4CHRM5CHRM1
SCHEMBL8042425 0.81 DRD2 (0.63) DRD2DRD3ADRA1DADRA1AADRA1B
SCHEMBL8042421 0.81 DRD2 (0.63) DRD2DRD3ADRA1DADRA1AADRA1B
SCHEMBL8045751 0.77 DRD2 (0.61) DRD2DRD4CHRM2CHRM4CHRM5
SCHEMBL8043711 0.77 DRD2 (0.61) DRD2DRD4CHRM2CHRM4CHRM5
SCHEMBL8043716 0.77 DRD2 (0.61) DRD2DRD4CHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6133275-A ALPHA 1 ADRENORECEPTOR ANTAGONISTS; TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER UROLOGICAL DISEASES E.G., BLADDER OUTLET OBSTRUCTION), NEUROGENIC BLADDER AND GYNECOLOGICAL SYNDROMES, E.G., DYSMENORRHEA; UTERINE MUSCLE RELAXANTS ABBOTT LABORATORIES (US) 2000-10-17 US disclosed